Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001474064-13-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-10 18:19:30
Reporting Period:
2013-04-08
Filing Date:
2013-04-10
Accepted Time:
2013-04-10 18:19:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
890465 Nps Pharmaceuticals Inc NPSP Biological Products, (No Disgnostic Substances) (2836) 870439579
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365343 Francois Nader 550 Hills Drive
Bedminster NJ 07921
President, Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-08 35,644 $5.73 272,504 No 4 M Direct
Common Stock Acquisiton 2013-04-08 7,632 $4.07 280,136 No 4 M Direct
Common Stock Acquisiton 2013-04-08 7,100 $4.50 287,236 No 4 M Direct
Common Stock Acquisiton 2013-04-08 6,567 $4.37 293,803 No 4 M Direct
Common Stock Acquisiton 2013-04-08 6,104 $4.31 299,907 No 4 M Direct
Common Stock Acquisiton 2013-04-08 55,470 $4.13 355,377 No 4 M Direct
Common Stock Acquisiton 2013-04-08 16,125 $4.42 371,502 No 4 M Direct
Common Stock Acquisiton 2013-04-08 15,358 $4.29 386,860 No 4 M Direct
Common Stock Disposition 2013-04-08 150,000 $11.01 236,860 No 4 S Direct
Common Stock Acquisiton 2013-04-09 79,356 $4.29 316,216 No 4 M Direct
Common Stock Acquisiton 2013-04-09 15,000 $4.10 331,216 No 4 M Direct
Common Stock Acquisiton 2013-04-09 13,875 $3.93 345,091 No 4 M Direct
Common Stock Acquisiton 2013-04-09 41,769 $3.85 386,860 No 4 M Direct
Common Stock Disposition 2013-04-09 150,000 $11.27 236,860 No 4 S Direct
Common Stock Acquisiton 2013-04-10 58,231 $3.85 295,091 No 4 M Direct
Common Stock Acquisiton 2013-04-10 16,754 $3.60 311,845 No 4 M Direct
Common Stock Acquisiton 2013-04-10 54,000 $3.34 365,845 No 4 M Direct
Common Stock Disposition 2013-04-10 148,367 $11.68 217,478 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2013-04-08 35,644 $0.00 35,644 $5.73
Common Stock Stock Option Disposition 2013-04-08 7,632 $0.00 7,632 $4.07
Common Stock Stock Option Disposition 2013-04-08 7,100 $0.00 7,100 $4.50
Common Stock Stock Option Disposition 2013-04-08 6,567 $0.00 6,567 $4.37
Common Stock Stock Option Disposition 2013-04-08 6,104 $0.00 6,104 $4.31
Common Stock Stock Option Disposition 2013-04-08 55,470 $0.00 55,470 $4.13
Common Stock Stock Option Disposition 2013-04-08 16,125 $0.00 16,125 $4.42
Common Stock Stock Option Disposition 2013-04-08 15,358 $0.00 15,358 $4.29
Common Stock Stock Option Disposition 2013-04-09 79,356 $0.00 79,356 $4.29
Common Stock Stock Option Disposition 2013-04-09 15,000 $0.00 15,000 $4.10
Common Stock Stock Option Disposition 2013-04-09 13,875 $0.00 13,875 $3.93
Common Stock Stock Option Disposition 2013-04-09 41,769 $0.00 41,769 $3.85
Common Stock Stock Option Disposition 2013-04-10 58,231 $0.00 58,231 $3.85
Common Stock Stock Option Disposition 2013-04-10 16,754 $0.00 16,754 $3.60
Common Stock Stock Option Disposition 2013-04-10 54,000 $0.00 54,000 $3.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
64,356 2016-06-05 No 4 M Direct
1,243 2016-07-17 No 4 M Direct
1,775 2016-10-16 No 4 M Direct
2,308 2017-01-16 No 4 M Direct
2,771 2017-04-16 No 4 M Direct
9,030 2017-07-02 No 4 M Direct
2,625 2017-07-16 No 4 M Direct
79,356 2017-09-10 No 4 M Direct
0 2017-09-10 No 4 M Direct
3,750 2017-10-15 No 4 M Direct
4,875 2018-01-15 No 4 M Direct
58,231 2018-03-17 No 4 M Direct
0 2018-03-17 No 4 M Direct
5,746 2018-04-15 No 4 M Direct
54,000 2020-02-19 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective November 28, 2012.
  2. Includes 734 shares of stock obtained through Issuer's Employee Stock Purchase Plan on 3/31/13.
  3. The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.00 and 11.04. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  4. The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.25 and 11.39. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  5. The price shown above represents the weighted average price of the shares sold. The range of sales prices was 11.65 and 11.71. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  6. On June 5, 2006, the Reporting Person received a grant of 100,000 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  7. On July 17, 2006, the Reporting Person received a grant of 8,875 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  8. On October 16, 2006, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  9. On January 16, 2007, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  10. On April 16, 2007, the Reporting Person received a grant of 8,875 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  11. On July 2, 2007, the Reporting Person received a grant of 64,500 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  12. On July 16, 2007, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  13. On September 10, 2007, the Reporting Person received a grant of 94,714 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant, 25% on the second anniversary of the date of grant, and 50% on the third anniversary of the date of grant.
  14. On October 15, 2007, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  15. On January 15, 2008, the Reporting Person received a grant of 18,750 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  16. On March 17, 2008, the Reporting Person received a grant of 100,000 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  17. On April 15, 2008, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
  18. On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On December 21, 2012, the performance criteria for 54,000 of these options was satisfied when the FDA unanimously voted to approve the NDA for GATTEX for the treatment of SBS. These options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.